Patent 6864265 Issued on March 8, 2005. Estimated Expiration Date: September 17, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/314, Additional hetero ring attached directly or indirectly to the quinoline ring system by nonionic bonding514/311, Quinolines (including hydrogenated)514/313, Nitrogen, other than as nitro or nitroso, attached directly to the six membered hetero ring by nonionic bonding546/135, Additional hetero ring containing546/160, Unsaturated carbocyclic ring bonded directly to the nitrogen546/159Nitrogen, other than as nitro or nitroso, attached directly to the six membered hetero ring by nonionic bonding
Compounds that bind to chemokine receptors such as CXCR4 and CCR5 demonstrate protective effects against infection of cells by human immunodeficiency virus are disclosed. These compounds contain a tertiary amine[[s]] linked to a core nitrogen via an aromatic or heteroaromatic moiety.
Other References
Database WPI AN209951, XP002189031.
Theodorou et al. (1997), Lancet 349:1219-1220.
Viardot et al. (1998). Ann. Hematol. 77:193-197.
Volin et al (1998). Biochem. Biophys. Res. Commun. 242:46-53.
Wyatt et al. (1998). Science 280:1884-1888.
Xia et al. (1999). J. NeuroVirology 5:32-41.
Yssel et al. (1998). Clinical and Experimental Allergy 28:104-109.
Zhang et al. (1997). AIDS Res. Hum. Retroviruses 13(16):1357-1366.
Zhang et al. (1998), J. Virol. 72:9307-9312.
Zhang et al. (1999). J. Virol. 73(4):3443-3448.
Zhang et al. (1999), J. Virol. 73(10):8256-8267.
Maekawa et al. (2000). Internal Medicine 39:90-100.
Michael et al. (1997). Nature Med. 3:338-340.
Michael et al. (1998), J. Virol. 72:6040-6047.
Miedema et al. (1994). Immune Rev. 140:35-72.
Moore et al. (1998). J. Invest. Med. 46:113-120.
Moore et al. (1998). Trends Cardiovasc. Med. 8:51-58.
Murdoch et al. (2000). Blood 95:3032-3043.
Nagasawa et al. (1996). Nature 382:635-638.
Nagase, et al. (2000). J. Immunol 164:5935-5943.
Nanki et al. (2000) J. Immunol 164:5010-5014.
Oberlin et al. (1996). Nature 382:833-835.
O'Brien et al. (1997). Lancet 349:1219.
Ohagen et al. (1999). J. Virol. 73(2):897-906.
Peled et al. (2000). Blood 95(11):3289-3296.
Peled et al. (1999). Science 283:845-848.
Ponath, P. (1998). Exp. Opin. Invest. Drugs7(1):1-18.
Qing et al. (1999). Immunity 10:463-471.
Rana et al. (1997). J. Virol. 71:3219-3227.
Rizzuto et al. (1998). Science 280:1949-1953.
Salcedo et al. (1999). Am. J. Pathol. 154(4):1125-1135.
Samson et al. (1996). Nature 381:722-725.
Sanders et al. (2000) J. Neuroscience Res. 59:671-679.
Schols et al. (1997). Antiviral Research 35:147-156.
Schols et al. (1997). J. Exp. Med. 186(8)1383-1388.
Schuitemaker et al. (1992). J. Virol. 66:1354-1360.
Seghal et al. (1998). J. Surg. Oncol. 69:99-104.
Simmons et al. (1969). J. Virol. 70(12):8355-8360.
Simmons et al. (1998). J. Virol. 72(10):8453-8457.
Tachibana et al. (1998). Nature 393:591-594.
Tersemette et al. (1988). J. Virol. 62(6):2026-2032.
Blaak et al. (2000). Proc. Natl. Acad. Sci. 97:1269-1274.
Blanco et al. (2000). Antimigrobial Agents and Chemother 44:51-56.
Bleul et al. (1998). J. Exp. Med. 187:753-762.
Bleul et al. (1996). Nature 382:829-833.
Bradstock et al. (2000). Leukemia 14:882-888.
Bridger et al. (1999). “Bicyclam Derivatives as HIV Inhibitors” in Advances in Antiviral Drug Design. vol. 3., JAI press, pp. 161-229.
Bridger et al. (1999). J. Med. Chem. 42:3971-3981.
Burger et al. (1999). Blood 94:3658-3667.
Buttini et al. (1998). Nature Med. 4:441-446.
Carroll et al. (1997). Science 276:273-276.
Cocchi et al. (1995). Science 270: 1811-1815.
Connor, R.I., Ho, D.D. (1994). J. Virol. 68:4400-4408.
Deng et al. (1996). Nature 381:661-666.
Donzella et al. (1998). Nature Medicine 4:72-77.
Dragic et al. (1996). Nature 381:667-673.
Egberink et al. (1999). J. Virol. 73:6346-6352.
Eitner et al. (1998). Transplantation 66:1551-1557.
Fedyk et al. (1999). J. Leukocyte Biol. 66:667-673.
Feng et al. (1996). Science 272:872-877.
Gonzalo et al. (2000). J . Immunol. 165:499-508.
Gupta et al. (1998). J. Biol. Chem. 7:4282-4287.
Herbein et al. (1998). Nature 395:189-194.
Hesselgesser et al. (1999). “Chemokines and Chemokine receptors in the Brain” in Chemokines in Disease, Humana Press, pp. 295-312.
Hesselgesser et al. (1997). Curr. Biol. 7:112-121.
Hesselgesser et al. (1998). Curr. Biol. 8:595-598.
Ishii et al. (1999). J.Immunol. 163:3612-3620.
Lataillade et al. (2000). Blood 95:756-768.
Liu et al. (1996). Cell 86:367-377.
Locati et al. (1999). Annu. Rev. Med. 50:425-40.
Abi-Younes et al. (2000). Circ. Res. 86:131-138.
Alkhatib et al. (1996). Science 272:1955-1958.
Arai et al. (2000). Eur. J. Haematol. 64:323-332.
Arenburg et al. (1997). J. Leukocyte Biol. 62:554-562.
Auiti et al. (1997). J. Exp. Med. 185:111-120.
Baggiolini, M. (1998). Nature 392:565-568.
Bajetto et al. (1999). J. Neurochem. 73:2348-2357.
Berger et al. (1999). Annu Rev. Immunol. 17:657-700.
Biard-Piechaczyk et al. (2000). Virology 268:329-344.